Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Active & Responsive
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
for
Retinitis Pigmentosa
Location: Dallas TX, Portland OR
Sponsor: Octant, Inc.
Sex: All
Age: 18+
Code: NCT07408232
Phase 1, Phase 2, Recruiting
Active & Responsive
Amblyopia Treatment for Children Aged 8 to 12 Years
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 8 - 12
Code: NCT07281742
Recruiting
Active & Responsive
Study of ALK-001 on the Progression of Stargardt Disease
for
Stargardt Disease
Location: Dallas TX, Fort Worth TX, San Antonio TX, Aurora CO,
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All
Age: 8 - 45
Code: NCT07419334
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Dallas TX, Oklahoma City OK, Edmond OK, Tulsa OK,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06977581
Phase 2, Recruiting
Active & Responsive
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Dallas TX, Mesquite TX, Austin TX, San Antonio TX,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Location: Dallas TX, St Louis MO, Birmingham AL, Atlanta GA,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05552157
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Dallas TX, Houston TX, San Antonio TX, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
for
Post Procedural Erythema
Location: Dallas TX, Tyler TX, The Woodlands TX, Boulder CO,
Sponsor: Acorn Biolabs Inc.
Sex: All
Age: 18+
Code: NCT06477172
Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)